Impairment of in vitro generation of monocyte-derived human dendritic cells by inactivated human immunodeficiency virus-1: Involvement of type I interferon produced from plasmacytoid dendritc cells

Human Immunology

Volumn 71, Issue 6, 2010, Pages 541-550

  Kodama, Akira ^a   Tanaka, Reiko ^a   Zhang, Li Feng ^a   Adachi, Tetsuya ^a   Saito, Mineki ^a   Ansari, Aftab A ^b   Tanaka, Yuetsu ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Apoptosis; Dendritic cells; HIV 1; Vaccination

Indexed keywords

ALPHA INTERFERON; CD123 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; FAS LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON; INTERFERON RECEPTOR; INTERLEUKIN 4; LYMPHOTOXIN; POLYINOSINIC POLYCYTIDYLIC ACID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; CXCR4 PROTEIN, HUMAN; CYTOKINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL DISRUPTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENRICHMENT CULTURE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; LEUKOCYTE CULTURE; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROCESS OPTIMIZATION; VIRUS INACTIVATION; CELL CULTURE; FOCAL ADHESION; GENETICS; HIV INFECTIONS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; T LYMPHOCYTE;

AIDS VACCINES; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; FOCAL ADHESIONS; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MONOCYTES; RECEPTORS, CCR5; RECEPTORS, CXCR4; T-LYMPHOCYTES; VIRUS INACTIVATION;

EID: 77952885201     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.02.020     Document Type: Article

References (49)

1. Schuler G., Schuler-Thurner B., Steinman R.M. The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 2003, 15:138-147.
2. Banchereau J., Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005, 5:296-306.
3. Figdor C.G., de Vries I.J., Lesterhuis W.J., Melief C.J. Dendritic cell immunotherapy: mapping the way. Nat Med 2004, 10:475-480.
4. Lu W., Wu X., Lu Y., Guo W., Andrieu J.M. Therapeutic dendritic-cell vaccine for simian AIDS. Nature 2003, 9:27-32.
5. Yoshida A., Tanaka R., Murakami T., Takahashi Y., Koyanagi Y., Nakamura M., et al. Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-cell origin. J Virol 2003, 77:8719-8728.
6. Lapenta C., Santini S.M., Logozzi M., Spada M., Andreotti M., Di Pucchio T., et al. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-α. J Exp Med 2003, 198:361-367.
7. Ide F., Nakamura T., Tomizawa M., Kawana-Tachikawa A., Odawara T., Hosoya N., Iwamoto A. Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial. J Med Virol 2006, 78:711-718.
8. Donaghy H., Pozniak A., Gazzard B., Qazi N., Gilmour J., Gotch F., Patterson S. Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 2001, 98:2574-2576.
9. + (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood 2001, 98:3016-3021.
10. + T-cell responses in HIV patients responding to antiretroviral therapy. Clin Immunol 2008, 128:228-237.
11. Fontaine J., Coutlee F., Tremblay C., Routy J.P., Poudrier J., Roger M. HIV infection affects blood myeloid dendritic cells after successful therapy and despite nonprogressing clinical disease. J Infect Dis 2009, 199:1007-1018.
12. Chehimi J., Campbell D.E., Azzoni L., Bacheller D., Papasavvas E., Jerandi G., et al. Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J Immunol 2002, 168:4796-4801.
13. Finke J.S., Shodell M., Shah K., Siegal F.P., Steinman R.M. Dendritic cell numbers in the blood of HIV-1 infected patients before and after changes in antiretroviral therapy. J Clin Immunol 2004, 24:647-652.
14. Ahlers J.D., Belyakov I.M. Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines. Trends Mol Med 2009, 15:263-274.
15. Dai B., Yang L., Yang H., Hu B., Baltimore D., Wang P. HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells. Proc Natl Acad Sci U S A 2009, 106:20382-20387.
16. + T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes. AIDS 2009, 23:1329-1340.
17. Timmerman J.M., Czerwinski D.K., Davis T.A., Hsu F.J., Benike C., Hao Z.M., et al. Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: Clinical and immune responses in 35 patients. Blood 2002, 99:1517-1526.
18. Jonuleit H., Giesecke-Tuettenberg A., Tuting T., Thurner-Schuler B., Stuge T.B., Paragnik L., et al. A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodaluntrianodal injection. Int J Cancer 2001, 93:243-251.
19. Berger T.G., Strasser E., Smith R., Carste C., Schuler-Thurner B., Kaempgen E., Schuler G. Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells. J Immunol Methods 2005, 298:61-72.
20. + monocytes to generate dendritic cells for cancer immunotherapy: A phase I study. J Hematother Stem Cell Res 2003, 12:515-523.
21. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 1994, 179:1109-1118.
22. Tawab A., Fan Y., Read E.J., Kurlander R.J. Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes. Transfusion 2009, 49:536-547.
23. Koski G.K., Lyakh L.A., Rice N.R. Rapid lipopolysaccharide-induced differentiation of CD14(+) monocytes into CD83(+) dendritic cells is modulated under serum-free conditions by exogenously added IFN-γ and endogenously produced IL-10. Eur J Immunol 2001, 31:3773-3781.
24. Dauer M., Obermaier B., Herten J., Haerle C., Pohl K., Rothenfusser S., et al. Mature dendritic cells derived from human monocytes within 48 hours: A novel strategy for dendritic cell differentiation from blood precursors. J Immunol 2003, 170:4069-4076.
25. Zhang L.F., Okuma K., Tanaka R., Kodama A., Kondo K., Ansari A.A., Tanaka Y. Generation of mature dendritic cells with unique phenotype and function by in vitro short-term culture of human monocytes in the presence of interleukin-4 and interferon-β. Exp Biol Med Maywood 2008, 233:721-731.
26. Dhodapkar M.V., Steinman R.M., Sapp M., Desai H., Fossella C., Krasovsky J., et al. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J Clin Invest 1999, 104:173-180.
27. Lehner M., Felzmann T., Clodi K., Holter W. Type I interferons in combination with bacterial stimuli induce apoptosis of monocyte-derived dendritic cells. Blood 2001, 98:736-742.
28. McRae B.L., Nagai T., Semnani R.T., van Seventer J.M., van Seventer G.A. Interferon-α and -β inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14(+) precursors. Blood 2000, 96:210-217.
29. Goxe B., Latour N., Chokri M., Abastado J.P., Salcedo M. Simplified method to generate large quantities of dendritic cells suitable for clinical applications. Immunol Investig 2000, 29:319-336.
30. Lund P.K., Westvik A.B., Joo G.B., Ovstebo R., Haug K.B., Kierulf P. Flow cytometric evaluation of apoptosis, necrosis and recovery when culturing monocytes. J Immunol Methods 2001, 252:45-55.
31. Lund P.K., Namork E., Brorson S.H., Westvik A.B., Joo G.B., Ovstebo R., Kierulf P. The fate of monocytes during 24 h of culture as revealed by flow cytometry and electron microscopy. J Immunol Methods 2002, 270:63-76.
32. Mangan D.F., Wahl S.M. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol 1991, 147:3408-3412.
33. Fahy R.J., Doseff A.I., Wewers M.D. Spontaneous human monocyte apoptosis utilizes a caspase-3-dependent pathway that is blocked by endotoxin and is independent of caspase-1. J Immunol 1999, 163:1755-1762.
34. Bohnenkamp H.R., Burchell J.M., Taylor-Papadimitriou J., Noll T. Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells. J Immunol Methods 2004, 294:67-80.
35. Yen J.H., Ganea D. Interferon β induces mature dendritic cell apoptosis through caspase-11/caspase-3 activation. Blood 2009, 114:1344-1354.
36. Luft T., Pang K.C., Thomas E., Hertzog P., Hart D.N., Trapani J., Cebon J. Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol 1998, 161:1947-1953.
37. Paquette R.L., Hsu N.C., Kiertscher S.M., Park A.N., Tran L., Roth M.D., Glaspy J.A. Interferon-α and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J Leukoc Biol 1998, 64:358-367.
38. Santini S.M., Lapenta C., Logozzi M., Parlato S., Spada M., Di Pucchio T., Belardelli F. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med 2000, 191:1777-1788.
39. Dauer M., Pohl K., Obermaier B., Meskendahl T., Robe J., Schnurr M., et al. Interferon-α disables dendritic cell precursors: Dendritic cells derived from interferon-α-treated monocytes are defective in maturation and T-cell stimulation. Immunology 2003, 110:38-47.
40. Gauzzi M.C., Canini I., Eid P., Belardelli F., Gessani S. Loss of type I IFN receptors and impaired IFN responsiveness during terminal maturation of monocyte-derived human dendritic cells. J Immunol 2002, 169:3038-3045.
41. + blood dendritic cells are potent producers of IFN-α in response to in vitro HIV-1 infection. J Immunol 1994, 152:4649-4662.
42. Francis M.L., Meltzer M.S. Induction of IFN-α by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication. J Immunol 1993, 151:2208-2216.
43. Beignon A.S., McKenna K., Skoberne M., Manches O., DaSilva I., Kavanagh D.G., et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005, 115:3265-3275.
44. Haupt S., Donhauser N., Chaipan C., Schuster P., Puffer B., Daniels R.S., et al. CD4 binding affinity determines human immunodeficiency virus type 1-induced α interferon production in plasmacytoid dendritic cells. J Virol 2008, 82:8900-8905.
45. Martinelli E., Cicala C., Van Ryk D., Goode D.J., Macleod K., Arthos J., Fauci A.S. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-α secretion in plasmacytoid dendritic cells. Proc Natl Acad Sci U S A 2007, 104:3396-3401.
46. Fonteneau J.F., Larsson M., Beignon A.S., McKenna K., Dasilva I., Amara A., et al. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J Virol 2004, 78:5223-5232.
47. Morse M.A., Zhou L.J., Tedder T.F., Lyerly H.K., Smith C. Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-α for use in cancer immunotherapy. Ann Surg 1997, 226:6-16.
48. Semnani R.T., Venugopal P.G., Mahapatra L., Skinner J.A., Meylan F., Chien D., et al. Induction of TRAIL- and TNF-α-dependent apoptosis in human monocyte-derived dendritic cells by microfilariae of Brugia malayi. J Immunol 2008, 181:7081-7089.
49. Baldwin H.M., Ito-Ihara T., Isaacs J.D., Hilkens C.M. TNFα blockade impairs dendritic cell survival and function in rheumatoid arthritis. Ann Rheum Dis 2009, in press.